NCT04099927View on ClinicalTrials.gov

A Study of SHR4010 in Patients With Hemodialysis

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 28, 2019

Primary Completion Date

April 20, 2020

Study Completion Date

June 15, 2020

Conditions
Pruritus
Interventions
DRUG

SHR0410

SHR0410 monotherapy,given intravenously

Trial Locations (1)

210009

Zhongda Hospital Affiliated to Southeast University, Nanjing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04099927 - A Study of SHR4010 in Patients With Hemodialysis | Biotech Hunter | Biotech Hunter